Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 125   

Articles published

JNJ 125.23 +0.77 (0.62%)
price chart
Johnson & Johnson Offered Woman $1.3 Million To “Keep Quiet” About Talcum ...
Johnson & Johnson is being hit with lawsuits all over the country over the link between their talcum powder and ovarian cancer.
3 Important Takeaways From Johnson & Johnson's Second-Quarter Earnings
Johnson & Johnson (NYSE:JNJ) is a healthcare Goliath that operates consumer healthcare, pharmaceuticals, and medical device businesses.
Why I'm Easing Off Johnson & Johnson  Seeking Alpha
Johnson & Johnson's Unstylish Sprawl Looks Good
Johnson & Johnson has bucked that trend, even as some of its units have struggled. But sometimes being out of step is the right move.
Can Johnson & Johnson Keep Soaring Higher?
Johnson & Johnson has been tracing out an almost completely uninterrupted rally since the mid-January low. This impressive performance includes six straight higher monthly highs as shares moved past the 2014 and 2015 peaks.
McDonald's Becomes #14 Most Shorted Dow Stock, Replacing Johnson & Johnson
The most recent short interest data has been released for the 07/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by “days to cover ...
Johnson & Johnson (JNJ) Stock Rises, CFO Talks M&A
NEW YORK (TheStreet) -- Shares of Johnson & Johnson (JNJ) are climbing 1.75% to $125.27 in afternoon trading today as the New Brunswick, NJ-based medical and pharmaceutical manufacturer's CFO Dominic Caruso says the company is considering ...
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter
Johnson & Johnson (JNJ) reported its second quarter 2016 earnings results on Tuesday, July 19. The company beat both revenue and earnings estimates for the quarter, helping to fuel continued momentum in U.S.
Analysts Advise About Johnson & Johnson (NYSE:JNJ)  Zergwatch
Noteworthy Analyst's Rating to Observe: Johnson & Johnson (NYSE:JNJ ...  Street Updates
Johnson & Johnson: 1 Dividend Stock to Own Forever
Healthcare and consumer goods companies might not sound as exciting as Internet ones, but in this ultra-low interest rate environment, it could be rewarding to take a look at Johnson & Johnson (NYSE:JNJ) stock. First of all, let's get one thing out of ...
Johnson & Johnson: Patience Finally Beginning To Pay Off  Seeking Alpha
Lynch Associatesin Lowers stake in Johnson & Johnson (JNJ)  Trade Calls
Johnson & Johnson (JNJ) Gets Price Target Hike at Deutsche Bank
Johnson & Johnson's pharmaceutical division is built to grow based on its "strong pipeline," while its medical devices sector should see improved sales growth depending on further restructuring efforts and portfolio management, the firm added.
How Did Johnson & Johnson's Segments Perform in 2Q16?  Market Realist
Teachers Advisors Inc. Has $538506000 Position in Johnson & Johnson (JNJ)  The Cerbat Gem
A really boring stock is one of Dow's top 5
But owning some shares of Tylenol maker Johnson & Johnson could help alleviate some of the pain. Johnson & Johnson (JNJ) is up 4% since the Brexit vote and has gained more than 18% this year. That's good enough to make J&J one of the top five Dow ...